mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.001 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.001 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |